Anaptysbio (ANAB) Change in Acquisitions & Divestments (2017 - 2026)

Anaptysbio's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $35.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 74.53% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $322.1 million (down 33.71% YoY) and the FY2025 annual result came in at $424.5 million, down 10.84% from the prior year.
• Change in Acquisitions & Divestments was $35.0 million for Q1 2026 at Anaptysbio, down from $73.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $149.2 million in Q4 2022 and bottomed at $9.6 million in Q1 2022.
• A 5-year average of $105.5 million and a median of $110.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments tumbled 84.8% — and 2023, when it surged 1294.24%.
• Anaptysbio's Change in Acquisitions & Divestments stood at $149.2 million in 2022, then dropped by 22.44% to $115.8 million in 2023, then fell by 20.75% to $91.7 million in 2024, then decreased by 19.89% to $73.5 million in 2025, then slumped by 52.38% to $35.0 million in 2026.
• Business Quant data shows ANAB's Change in Acquisitions & Divestments at $35.0 million in Q1 2026, $73.5 million in Q4 2025, and $123.0 million in Q3 2025.